Compare Moderna, Inc. (MRNA) vs Petróleo Brasileiro SA (PBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Petróleo Brasileiro SA — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Petróleo Brasileiro SA trades at $18.51 (market cap $108.78B). The key difference: Petróleo Brasileiro SA is far larger — about 4.6× Moderna, Inc.'s market cap, and Petróleo Brasileiro SA pays a 9.81% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | PBR | |
|---|---|---|
Market Cap | $23.60B | $108.78B |
Sector | Health | Technology |
52-Week High | $81.80 | $22.03 |
52-Week Low | $22.36 | $11.54 |
Enterprise Value | $19.70B | $171.32B |
Dividend Yield | — | 9.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Petróleo Brasileiro SA
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →
